Impact of adherence to biological agents on health care resource utilization for patients over the age of 65 years with rheumatoid arthritis

por Lathia, Urja, Ewara, Emmanuel M, Nantel, Francois
Publicado 2017

Persistence to subcutaneous biological agents in Hungarian patients treated for inflammatory arthritis

por Takacs, Peter, Lathia, Urja, Shin, Janey, Nantel, Francois
Publicado 2019

Adherence and dosing interval of subcutaneous antitumour necrosis factor biologics among patients with inflammatory arthritis: analysis from a Canadian administrative database

por Bhoi, Peter, Bessette, Louis, Bell, Mary J, Tkaczyk, Cathy, Nantel, Francois, Maslova, Karina
Publicado 2017

Long-term effectiveness and safety of infliximab, golimumab and ustekinumab in patients with psoriatic arthritis from a Canadian prospective observational registry

por Rahman, Proton, Arendse, Regan, Khraishi, Majed, Sholter, Dalton, Sheriff, Maqbool, Rampakakis, Emmanouil, Lehman, Allen J, Nantel, Francois
Publicado 2020

Long-term effectiveness and safety of infliximab and golimumab in ankylosing spondylitis patients from a Canadian prospective observational registry

por Rahman, Proton, Starr, Michael, Haaland, Derek, Bessette, Louis, Teo, Michelle, Rampakakis, Emmanouil, Lehman, Allen J., Nantel, Francois
Publicado 2020

Usage and Adherence of Seven Advanced Therapies with Differing Mechanisms of Action for Inflammatory Arthritis in Canada

por Nantel, Francois, Ling, Juejing, Rachich, Meagan, Asin-Milan, Odalis, Millson, Brad, Golden, Shane, Yang, Huijuan, Barot, Purva, Lehman, Allen J.
Publicado 2022

Long-term effectiveness and safety of infliximab, golimumab and golimumab-IV in rheumatoid arthritis patients from a Canadian prospective observational registry

por Rahman, Proton, Baer, Philip, Keystone, Ed, Choquette, Denis, Thorne, Carter, Haraoui, Boulos, Chow, Andrew, Faraawi, Rafat, Olszynski, Wojciech, Kelsall, John, Rampakakis, Emmanouil, Lehman, Allen J., Nantel, Francois
Publicado 2020

Real-world validation of the minimal disease activity index in psoriatic arthritis: an analysis from a prospective, observational, biological treatment registry

por Rahman, Proton, Zummer, Michel, Bessette, Louis, Baer, Philip, Haraoui, Boulos, Chow, Andrew, Kelsall, John, Kapur, Suneil, Rampakakis, Emmanouil, Psaradellis, Eliofotisti, Lehman, Allen J, Nantel, Francois, Osborne, Brendan, Tkaczyk, Cathy
Publicado 2017

Use of corticosteroids in patients with rheumatoid arthritis treated with infliximab: treatment implications based on a real-world Canadian population

por Haraoui, Boulos, Jovaisas, Algis, Bensen, William G, Faraawi, Rafat, Kelsall, John, Dixit, Sanjay, Rodrigues, Jude, Sheriff, Maqbool, Rampakakis, Emmanouil, Sampalis, John S, Lehman, Allen J, Otawa, Susan, Nantel, Francois, Shawi, May
Publicado 2015

Biologic Treatment Registry Across Canada (BioTRAC): a multicentre, prospective, observational study of patients treated with infliximab for ankylosing spondylitis

por Rahman, Proton, Choquette, Denis, Bensen, William G, Khraishi, Majed, Chow, Andrew, Zummer, Michel, Shaikh, Saeed, Sheriff, Maqbool, Dixit, Sanjay, Sholter, Dalton, Psaradellis, Eliofotisti, Sampalis, John S, Letourneau, Vincent, Lehman, Allen J, Nantel, François, Rampakakis, Emmanouil, Otawa, Susan, Shawi, May
Publicado 2016